Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium in COPD Patients with Acute Respiratory Infection
NCT01483625Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Primary endpoint: Trough Forced Expiratory Volume in 1 Second at 12 weeks. Started Nov 2011; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01483625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01483625.